Detalhe da pesquisa
1.
Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE).
Antimicrob Agents Chemother
; 67(4): e0119322, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36975790
2.
Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
JAMA
; 321(21): 2101-2112, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31162568
3.
ELISA F29 -A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment.
PLoS Negl Trop Dis
; 17(6): e0011440, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352322
4.
Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO).
PLoS Negl Trop Dis
; 15(1): e0008912, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33412557
5.
Integrated micro/messenger RNA regulatory networks in essential thrombocytosis.
PLoS One
; 13(2): e0191932, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29420626
6.
No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects.
Thyroid
; 27(9): 1118-1127, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28741453
7.
Platelet genetic biomarker quantification: comparison of fluorescent microspheres and PCR platforms.
Thromb Haemost
; 109(2): 337-46, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23223848